Doxorubicin hydrochloride is an aperiodic specific antitumor drug with a wide antitumor spectrum and can be used for breast cancer, lung cancer, lymphatic cancer, ovarian cancer and other cancers. As a second-line antitumor agent, doxorubicin can be used for treatment when drug resistance is the first choice.